P21 gene expression as an indication for the activity of adenovirus-p53 gene therapy in non-small cell lung cancer patients

Cancer Gene Therapy

Volumn 7, Issue 9, 2000, Pages 1215-1219

  Boulay, Jean Louis ^a   Perruchoud, André P ^a   Reuter, Juergen ^a   Bolliger, Christoph ^a   Herrmann, Richard ^a   Rochlitz, Christoph ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Cancer; Chemotherapy; Clinical trial; Gene therapy; p53

Indexed keywords

BIOLOGICAL MARKER; CISPLATIN; NAVELBINE; PROTEIN P21; PROTEIN P53;

ADENOCARCINOMA; ARTICLE; CELL CYCLE; CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; TUMOR REGRESSION;

ADENOVIRIDAE;

EID: 0033781847     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700227     Document Type: Article

References (11)

1. p53, The cellular gatekeeper for growth and division
2. p53-Dependent apoptosis modulates the cytotoxicity of anticancer agents
3. Genetic mechanisms of tumor suppression by the human p53 gene
4. p53 Status and the efficacy of cancer therapy in vivo
5. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer
6. A phase I study of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer
7. Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line
8. WAF1, a potential mediator of p53 tumor suppression
9. 1 cyclin-dependent kinases
10. A model for p53-induced apoptosis
11. Wild-type p53 triggers a rapid senescence program in human tumor cells lacking p53